Cargando…

Factors influencing transfection efficiency of pIDUA/nanoemulsion complexes in a mucopolysaccharidosis type I murine model

Mucopolysaccharidosis type I (MPS I) is an autosomal disease caused by alpha-l-iduronidase (IDUA) deficiency. This study used IDUA knockout mice as a model to evaluate whether parameters such as dose of plasmid and time of treatment could influence the transfection efficiency of complexes formed wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fraga, Michelle, de Carvalho, Talita Giacomet, Bidone, Juliana, Schuh, Roselena Silvestri, Matte, Ursula, Teixeira, Helder Ferreira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5358998/ https://www.ncbi.nlm.nih.gov/pubmed/28352175 http://dx.doi.org/10.2147/IJN.S121558

Ejemplares similares

Drug Repositioning Applied to Cardiovascular Disease in Mucopolysaccharidosis
por: Villalba Silva, Gerda Cristal, et al.
Publicado: (2022)

Effects of Enzyme Replacement Therapy Started Late in a Murine Model of Mucopolysaccharidosis Type I
por: Pasqualim, Gabriela, et al.
Publicado: (2015)

Drosophila D-idua Reduction Mimics Mucopolysaccharidosis Type I Disease-Related Phenotypes
por: De Filippis, Concetta, et al.
Publicado: (2021)

Quantification of Idua Enzymatic Activity Combined with Observation of Phenotypic Change in Zebrafish Embryos Provide a Preliminary Assessment of Mutated idua Correlated with Mucopolysaccharidosis Type I
por: Lin, Cheng-Yung, et al.
Publicado: (2022)

Influence of phospholipid composition on cationic emulsions/DNA complexes: physicochemical properties, cytotoxicity, and transfection on Hep G2 cells
por: Fraga, Michelle, et al.
Publicado: (2011)

A deletion of IDUA exon 10 in a family of Golden Retriever dogs with an attenuated form of mucopolysaccharidosis type I
por: Faller, Kiterie M. E., et al.
Publicado: (2020)

Which Is the Best In Silico Program for the Missense Variations in IDUA Gene? A Comparison of 33 Programs Plus a Conservation Score and Evaluation of 586 Missense Variants
por: Borges, Pâmella, et al.
Publicado: (2021)

A novel p.E276K IDUA mutation decreasing α-L-iduronidase activity causes mucopolysaccharidosis type I
por: Prommajan, Korrakot, et al.
Publicado: (2011)

Mucopolysaccharidosis type I in 21 Czech and Slovak patients: Mutation analysis suggests a functional importance of C-terminus of the IDUA protein
por: Vazna, Alzbeta, et al.
Publicado: (2009)

Antiherpes Activity and Skin/Mucosa Distribution of Flavonoids from Achyrocline satureioides Extract Incorporated into Topical Nanoemulsions
por: Bidone, Juliana, et al.
Publicado: (2015)

Nanoemulsions as Gene Delivery in Mucopolysaccharidosis Type I—A Mini-Review
por: Zapolnik, Paweł, et al.
Publicado: (2022)

Mucopolysaccharidosis Type I
por: Kubaski, Francyne, et al.
Publicado: (2020)

Maternal mosaicism for IDUA deletion clarifies recurrence risk in MPS I
por: Breen, Catherine, et al.
Publicado: (2016)

Novel splice site IDUA gene mutation in Tunisian pedigrees with hurler syndrome
por: Chkioua, Latifa, et al.
Publicado: (2018)

Achyrocline satureioides (Lam.) DC (Asteraceae) Extract-Loaded Nanoemulsions as a Promising Topical Wound Healing Delivery System: In Vitro Assessments in Human Keratinocytes (HaCaT) and HET-CAM Irritant Potential
por: Balestrin, Lucélia Albarello, et al.
Publicado: (2021)

Curcumin and Quercetin-Loaded Nanoemulsions: Physicochemical Compatibility Study and Validation of a Simultaneous Quantification Method
por: Vaz, Gustavo Richter, et al.
Publicado: (2020)

IDUA Gene Variants and Response to Zoledronic Acid Treatment in Chinese Women with Postmenopausal Osteoporosis
por: Lin, Haiqing, et al.
Publicado: (2021)

Comment on “report of 5 novel mutations of the α-L-iduronidase gene and comparison of Korean mutations in relation with those of Japan or China in patients with mucopolysaccharidosis I”
por: Poletto, Edina, et al.
Publicado: (2018)

Curcumin and Quercetin-Loaded Lipid Nanocarriers: Development of Omega-3 Mucoadhesive Nanoemulsions for Intranasal Administration
por: Vaz, Gustavo Richter, et al.
Publicado: (2022)

Efficient IDUA Gene Mutation Detection with Combined Use of dHPLC and Dried Blood Samples
por: Ribeiro, Diogo, et al.
Publicado: (2013)

A Biochemical Platform to Define the Relative Specific Activity of IDUA Variants Identified by Newborn Screening
por: Yu, Seok-Ho, et al.
Publicado: (2020)

In silico analysis of potential off-target sites to gene editing for Mucopolysaccharidosis type I using the CRISPR/Cas9 system: Implications for population-specific treatments
por: Carneiro, Paola, et al.
Publicado: (2022)

Decreased performance in IDUA knockout mouse mimic limitations of joint function and locomotion in patients with Hurler syndrome
por: Kim, Chihwa, et al.
Publicado: (2015)

Novel frameshift variant in the IDUA gene underlies Mucopolysaccharidoses type I in a consanguineous Yemeni pedigree
por: Azab, Belal, et al.
Publicado: (2017)

Distribution of Heparan Sulfate Oligosaccharides in Murine Mucopolysaccharidosis Type IIIA
por: Mason, Kerryn, et al.
Publicado: (2014)

Neurocognitive testing in a murine model of mucopolysaccharidosis type IIIA
por: Pericleous, Kleopatra, et al.
Publicado: (2023)

Optimization of Gene Transfection in Murine Myeloma Cell Lines using Different Transfection Reagents
por: Shabani, Mahdi, et al.
Publicado: (2010)

Ocular Tolerability and Immune Response to Corneal Intrastromal AAV-IDUA Gene Therapy in New Zealand White Rabbits
por: Song, Liujiang, et al.
Publicado: (2020)

Identification of a novel compound heterozygous IDUA mutation underlies Mucopolysaccharidoses type I in a Chinese pedigree
por: Zhou, Yong‐An, et al.
Publicado: (2019)

Treatment of adult MPSI mouse brains with IDUA-expressing mesenchymal stem cells decreases GAG deposition and improves exploratory behavior
por: da Silva, Flávia Helena, et al.
Publicado: (2012)

Increased Glutamate Receptor and Transporter Expression in the Cerebral Cortex and Striatum of Gcdh (-/-) Mice: Possible Implications for the Neuropathology of Glutaric Acidemia Type I
por: Lagranha, Valeska Lizzi, et al.
Publicado: (2014)

Development of Substrate Degradation Enzyme Therapy for Mucopolysaccharidosis IVA Murine Model
por: Sawamoto, Kazuki, et al.
Publicado: (2019)

Associations of IDUA and PTCH1 with Bone Mineral Density, Bone Turnover Markers, and Fractures in Chinese Elderly Patients with Osteoporosis
por: Wang, Qifei, et al.
Publicado: (2019)

“Missing mutations” in MPS I: Identification of two novel copy number variations by an IDUA‐specific in house MLPA assay
por: Jahic, Amir, et al.
Publicado: (2019)

Immunological evaluation of patients with mucopolysaccharidosis (MPS)
por: Aranda, Carolina, et al.
Publicado: (2015)

Sexual behaviour in a murine model of mucopolysaccharidosis type I (MPS I)
por: Barbosa Mendes, Ana, et al.
Publicado: (2019)

Mucopolysaccharidosis VI
por: Valayannopoulos, Vassili, et al.
Publicado: (2010)

The Murine Model of Mucopolysaccharidosis IIIB Develops Cardiopathies over Time Leading to Heart Failure
por: Schiattarella, Gabriele Giacomo, et al.
Publicado: (2015)

Microalbuminuria en pacientes con diabetes mellitus tipo 2 de 10 años de evolución
por: Bello Ramírez, Roselena
Publicado: (2001)

Airway Abnormalities in Adult Mucopolysaccharidosis and Development of Salford Mucopolysaccharidosis Airway Score
por: Gadepalli, Chaitanya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fn9c7p0e411892vgp220o16dtl